Our strengths

Why should you entrust us with your projects?

Our approach

Our approach

Atessia +

"Research Tax Credit" approval issued by the Ministry of Research.

ATESSIA is committed to its clients in order to facilitate their Research and Development work. In 2019, ATESSIA applied for and successfully obtained its CIR (Research Tax Credit) accreditation issued by the Ministry of Higher Education, Research and Innovation (MESRI). The accreditation is valid for 3 years and can be renewed.

Thus, our clients will be able to benefit from a corporate tax refund at the end of the fiscal year as a result of the CIR accreditation. Indeed, the expenses that can give right to the CIR are the R&D expenses entrusted either to public organisations, universities, public utility foundations and associations under the 1901 law engaged in Research and Development, or to organizations approved by the Ministry in charge of Research.

The tax credit will therefore be valid for contractual services provided that the work undertaken meets the requirements of Research and Development.

Do not hesitate to contact us for any questions. Our team dedicated to R&D projects is at your disposal.

Training organization referenced in the Datadock database.

ATESSIA is SME certified by the European Medicines Agency.

ATESSIA is an innovative company that can help you innovate and access the European market!

SMEs are a driver of innovation in the pharmaceutical sector and play a key role in the development of new medicines.

But for small companies, finding their way through EU rules and regulations can be a challenge.

ATESSIA is SME certified by the European Medicines Agency.

The SME initiative has been put in place by the EMA in order to promote innovation and the development of new medicinal products by smaller companies.

The EU incentives offered by EMA apply to both the human and veterinary sectors, and include:

  • Regulatory, administrative and procedural assistance from the Agency’s SME office including SME briefing meetings
  • Fee incentives (reductions, exemptions) for regulatory procedures such as Scientific advice on medicine development plans, MA applications, Inspections.
  • After MA approval, EMA also provides translations of product information in all EU languages, free of charge.

ATESSIA can make non-EEA SME companies benefit from the European Medicines Agency SME incentives : SME regulatory consultancies may seek to benefit from the provisions of the SME Regulation on behalf of non-EEA based clients, if both they and the client meet the SME criteria:

Headcount: The company and its subsidiaries should have less than 250 employees

Financial thresholds:  Annual turnover  € 50 million or Balance sheet € 43 million

"Research Tax Credit" approval issued by the Ministry of Research.

ATESSIA is committed to its clients in order to facilitate their Research and Development work. In 2019, ATESSIA applied for and successfully obtained its CIR (Research Tax Credit) accreditation issued by the Ministry of Higher Education, Research and Innovation (MESRI). The accreditation is valid for 3 years and can be renewed.

Thus, our clients will be able to benefit from a corporate tax refund at the end of the fiscal year as a result of the CIR accreditation. Indeed, the expenses that can give right to the CIR are the R&D expenses entrusted either to public organisations, universities, public utility foundations and associations under the 1901 law engaged in Research and Development, or to organizations approved by the Ministry in charge of Research.

The tax credit will therefore be valid for contractual services provided that the work undertaken meets the requirements of Research and Development.

Do not hesitate to contact us for any questions. Our team dedicated to R&D projects is at your disposal.

Training organization referenced in the Datadock database.


ATESSIA is SME certified by the European Medicines Agency.

ATESSIA is an innovative company that can help you innovate and access the European market!

SMEs are a driver of innovation in the pharmaceutical sector and play a key role in the development of new medicines.

But for small companies, finding their way through EU rules and regulations can be a challenge.

ATESSIA is SME certified by the European Medicines Agency.

The SME initiative has been put in place by the EMA in order to promote innovation and the development of new medicinal products by smaller companies.

The EU incentives offered by EMA apply to both the human and veterinary sectors, and include:

  • Regulatory, administrative and procedural assistance from the Agency’s SME office including SME briefing meetings
  • Fee incentives (reductions, exemptions) for regulatory procedures such as Scientific advice on medicine development plans, MA applications, Inspections.
  • After MA approval, EMA also provides translations of product information in all EU languages, free of charge.

ATESSIA can make non-EEA SME companies benefit from the European Medicines Agency SME incentives : SME regulatory consultancies may seek to benefit from the provisions of the SME Regulation on behalf of non-EEA based clients, if both they and the client meet the SME criteria:

Headcount: The company and its subsidiaries should have less than 250 employees

Financial thresholds:  Annual turnover  € 50 million or Balance sheet € 43 million

Our values